Cargando…

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research

The rapidly growing field of functional, molecular and structural bio-imaging is providing an extraordinary new opportunity to overcome the limits of invasive liver biopsy and introduce a “digital biopsy” for in vivo study of liver pathophysiology. To foster the application of bio-imaging in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mancini, Marcello, Summers, Paul, Faita, Francesco, Brunetto, Maurizia R, Callea, Francesco, De Nicola, Andrea, Di Lascio, Nicole, Farinati, Fabio, Gastaldelli, Amalia, Gridelli, Bruno, Mirabelli, Peppino, Neri, Emanuele, Salvadori, Piero A, Rebelos, Eleni, Tiribelli, Claudio, Valenti, Luca, Salvatore, Marco, Bonino, Ferruccio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838442/ https://www.ncbi.nlm.nih.gov/pubmed/29527259 http://dx.doi.org/10.4254/wjh.v10.i2.231

Ejemplares similares

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
por: De Rosa, Laura, et al.
Publicado: (2022)

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
por: Bonino, Ferruccio, et al.
Publicado: (2022)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
por: Colombatto, Piero, et al.
Publicado: (2022)

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease
por: Yuan, Quan, et al.
Publicado: (2015)

Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral (18)FDG in Mice
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Maternal High-Fat Feeding Affects the Liver and Thymus Metabolic Axis in the Offspring and Some Effects Are Attenuated by Maternal Diet Normalization in a Minipig Model
por: La Rosa, Federica, et al.
Publicado: (2021)

Thermal Care of Functional Dyspepsia Based on Bicarbonate-Sulphate-Calcium Water: A Sequential Clinical Trial
por: Rocca, Giuseppe, et al.
Publicado: (2007)

T cell receptor-therapy in HBV-related hepatocellularcarcinoma
por: Bertoletti, Antonio, et al.
Publicado: (2015)

Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet
por: Guzzardi, Maria Angela, et al.
Publicado: (2021)

Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs
por: Novellino, Luisa, et al.
Publicado: (2012)

A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection
por: Brunetto, Maurizia Rossana, et al.
Publicado: (2014)

Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Urgent Liver Transplantation Soon After Recovery From COVID‐19 in a Patient With Decompensated Liver Cirrhosis
por: Martini, Silvia, et al.
Publicado: (2020)

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
por: Marcellin, Patrick, et al.
Publicado: (2012)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
por: Cavallone, Daniela, et al.
Publicado: (2023)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Liver-targeting drugs and their effect on blood glucose and hepatic lipids
por: Gastaldelli, Amalia, et al.
Publicado: (2021)

External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2018)

Ultrasonographic Characterization of the db/db Mouse: An Animal Model of Metabolic Abnormalities
por: Faita, Francesco, et al.
Publicado: (2018)

An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study
por: Germanese, Danila, et al.
Publicado: (2019)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022)

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib
por: Colombatto, Piero, et al.
Publicado: (2021)

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
por: Carli, Fabrizia, et al.
Publicado: (2023)

A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients
por: Cioni, Dania, et al.
Publicado: (2022)

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage
por: Rossi, Chiara, et al.
Publicado: (2022)

Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease
por: Gaggini, Melania, et al.
Publicado: (2019)

Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies
por: Gorini, Francesca, et al.
Publicado: (2020)

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases
por: Bocci, Guido, et al.
Publicado: (2022)

Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
por: Svegliati-Baroni, Gianluca, et al.
Publicado: (2020)

Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study
por: Cillo, Umberto, et al.
Publicado: (2013)

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
por: Crotta, Stefania, et al.
Publicado: (2002)

Numerical simulation of novel concept 4D cardiac microtomography for small rodents based on all-optical Thomson scattering X-ray sources
por: Panetta, Daniele, et al.
Publicado: (2019)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ncuk609danak2gfte49qb57cu